F11009—Lung Biology and Translational Medicine

Contact:

Mentor:  Veena B. Antony, M.D., Professor of Medicine,  Pulmonary, Allergy and Critical Care Medicine  Mailing Address:  UAB Division of Pulmonary, Allergy and Critical Care Medicine  1900 University Blvd. THT-413, Birmingham, AL  35294-0006  Telephone:  (205) 975-3258  Fax:  (205) 934-1721; Email:  This email address is being protected from spambots. You need JavaScript enabled to view it.


Lung Biology and Translational Medicine

Contact: Veena B. Antony, M.D., Professor of Medicine,  Pulmonary, Allergy and Critical Care Medicine  Mailing Address:  UAB Division of Pulmonary, Allergy and Critical Care Medicine  1900 University Blvd. THT-413, Birmingham, AL  35294-0006  Telephone:  (205) 975-3258  Fax:  (205) 934-1721; Email:  This email address is being protected from spambots. You need JavaScript enabled to view it.

 Postdoctoral Position Available

 Postdoctoral positions funded through a T32 training grant are currently available to MD and PhD prepared trainees for careers in clinical and translational, and basic research in lung biology and medicine with a focus on stem cells and mechanisms of tissue repair and regeneration.

Research projects include studies in the pathophysiology and treatment of pulmonary fibrosis, emphysema and chronic airway inflammation; basic mechanisms in cell signaling, including biomechanical and biochemical effects of the extracellular matrix; molecular and cellular mechanisms of stem cell differentiation/fate and tissue response to injury; pathophysiology and treatment of chronic lung disease, free radicals, oxidative injury and antioxidants in pulmonary diseases.

Application Requirements:  The candidate must be a US citizen or permanent resident.  Candidate must have an M.D. or Ph.D. degree.  The position is available for 2-3 years, with additional opportunities for future funding.  Successful candidates should demonstrate a strong commitment to an academic research career.  Individuals are invited to send a current CV, a letter indicating an interest and describing research accomplishments and plans, and the names and contact information of three references to Dr. Veena B. Anthony, E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Funding Available:  Amount of award is dependent on the applicant’s experience and follows NIH guidelines

UAB News

  • As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.

  • effrey R. Curtis, M.D., from the University of Alabama at Birmingham, and colleagues utilized 1998 to 2011 data from the U.S. Veterans Health Administration to identify RA patients initiating rituximab, abatacept, or anti-tumor necrosis factor (anti-TNF) therapy. The authors sought to assess the comparative risk of hospitalized infection associated with anti-TNF and non-anti-TNF biologic agents.

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...